Literature DB >> 27350016

Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy - Comparative Strain Imaging Study.

Cesare de Gregorio1, Giuseppe Dattilo, Matteo Casale, Anna Terrizzi, Rocco Donato, Gianluca Di Bella.   

Abstract

BACKGROUND: We sought to assess left atrial (LA) morphology and function in patients with transthyretin cardiac amyloidosis (TTR-CA) and hypertrophic cardiomyopathy (HCM). Primarily, longitudinal deformation (reservoir) and pump function were the focus of vector-velocity strain echocardiography imaging. METHODS AND 
RESULTS: The study group comprised 32 patients (mean age 57.7±15.4 years, 16 in each group), and 15 healthy controls. Diagnosis of TTR-CA was based on echocardiography and either gadolinium-enhanced (LGE) cardiac magnetic resonance (cMRI) or radionuclide imaging. At baseline, there were no differences in age, body surface area, blood pressure and risk factors among the groups. Left ventricular (LV) mass was greater in patients than in controls, and slight LA dilatation was found in the TTR-CA group. LA reservoir was 14.1±4.7% in TTR-CA, 20.0±5.6% in HCM, and 34.0±11.8% in controls (<0.001). In addition, LA pump function chiefly was impaired in the former group, irrespective of LA chamber size and LV ejection fraction. LGE in the atrial wall was seen in 9/10 TTR-CA versus 0/8 HCM patients undergoing cMRI (P<0.001). LA reservoir ≤19% and pump function ≤-1.1% best discriminated TTR-CA from HCM patients in the receiver-operating characteristic analysis.
CONCLUSIONS: LA reservoir and pump function were significantly impaired in both TTR-CA and HCM patients compared with controls, but mainly in the former group, irrespective of LA volume and LV ejection fraction, likely caused by a more altered LA wall structure. (Circ J 2016; 80: 1830-1837).

Entities:  

Mesh:

Year:  2016        PMID: 27350016     DOI: 10.1253/circj.CJ-16-0364

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

Review 1.  How to Image Cardiac Amyloidosis: A Practical Approach.

Authors:  Sharmila Dorbala; Sarah Cuddy; Rodney H Falk
Journal:  JACC Cardiovasc Imaging       Date:  2019-10-11

2.  Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.

Authors:  Giorgio Treglia; Andor W J M Glaudemans; Francesco Bertagna; Bouke P C Hazenberg; Paola A Erba; Raffaele Giubbini; Luca Ceriani; John O Prior; Luca Giovanella; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-23       Impact factor: 9.236

3.  A Novel Missense Mutation p.Gly162Glu of the Gene MYL2 Involved in Hypertrophic Cardiomyopathy: A Pedigree Analysis of a Proband.

Authors:  Pauline Renaudin; Alexandre Janin; Gilles Millat; Philippe Chevalier
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

4.  Left atrial remodeling and the prognostic value of feature tracking derived left atrial strain in patients with light-chain amyloidosis: a cardiovascular magnetic resonance study.

Authors:  Zekun Tan; Yuelong Yang; Wenjian Wang; Hui Liu; Xinyi Wu; Sheng Li; Liwen Li; Liye Zhong; Qiongwen Lin; Hongwen Fei; Pengjun Liao
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-03       Impact factor: 2.357

5.  Clinical Utility of Left Atrial Asynchrony and Mechanical Function in Patients with Hypertrophic Cardiomyopathy.

Authors:  Ozkan Candan; Cetin Gecmen; Muzaffer Kahyaoğlu; Zeki Şimsek; Mehmet Çelik; Abdulkadir Uslu; Cevat Kirma
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

6.  Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.

Authors:  Maarten P van den Berg; Bart A Mulder; Sebastiaan H C Klaassen; Alexander H Maass; Dirk J van Veldhuisen; Peter van der Meer; Hans L A Nienhuis; Bouke P C Hazenberg; Michiel Rienstra
Journal:  Eur Heart J       Date:  2019-04-21       Impact factor: 29.983

7.  Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.

Authors:  Jack Brownrigg; Massimiliano Lorenzini; Matthew Lumley; Perry Elliott
Journal:  ESC Heart Fail       Date:  2019-09-05

8.  Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement.

Authors:  Diana Bonderman; Gerhard Pölzl; Klemens Ablasser; Hermine Agis; Stefan Aschauer; Michaela Auer-Grumbach; Christina Binder; Jakob Dörler; Franz Duca; Christian Ebner; Marcus Hacker; Renate Kain; Andreas Kammerlander; Matthias Koschutnik; Alexander Stephan Kroiss; Agnes Mayr; Christian Nitsche; Peter P Rainer; Susanne Reiter-Malmqvist; Matthias Schneider; Roland Schwarz; Nicolas Verheyen; Thomas Weber; Marc Michael Zaruba; Roza Badr Eslam; Martin Hülsmann; Julia Mascherbauer
Journal:  Wien Klin Wochenschr       Date:  2020-12-03       Impact factor: 1.704

Review 9.  Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis.

Authors:  Paul J Scheel; Monica Mukherjee; Allison G Hays; Joban Vaishnav
Journal:  Front Cardiovasc Med       Date:  2022-03-24

10.  Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis.

Authors:  Fumi Oike; Hiroki Usuku; Eiichiro Yamamoto; Kyohei Marume; Seiji Takashio; Masanobu Ishii; Noriaki Tabata; Koichiro Fujisue; Kenshi Yamanaga; Daisuke Sueta; Shinsuke Hanatani; Yuichiro Arima; Satoshi Araki; Seitaro Oda; Hiroaki Kawano; Hirofumi Soejima; Kenichi Matsushita; Mitsuharu Ueda; Toshihiro Fukui; Kenichi Tsujita
Journal:  ESC Heart Fail       Date:  2022-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.